Safety profile of poly (ADP-ribose) polymerase (PARP) inhibitors in cancer: a network meta-analysis of randomized controlled trials

BACKGROUND: Poly (ADP-ribose) polymerase (PARP) inhibitors, which are among the most important breakthroughs in precision medicine, have played a crucial role in cancer treatment. Understanding the toxicity profiles of the different PARP inhibitors will improve strategic treatment in clinical practi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bao, Shengnan, Yue, Yuanping, Hua, Yijia, Zeng, Tianyu, Yang, Yiqi, Yang, Fan, Yan, Xueqi, Sun, Chunxiao, Yang, Mengzhu, Fu, Ziyi, Huang, Xiang, Li, Jun, Wu, Hao, Li, Wei, Zhao, Yang, Yin, Yongmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421942/
https://www.ncbi.nlm.nih.gov/pubmed/34532366
http://dx.doi.org/10.21037/atm-21-1883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421942/
https://www.ncbi.nlm.nih.gov/pubmed/34532366
http://dx.doi.org/10.21037/atm-21-1883

Ejemplares similares